Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion

Chest

Volumn 142, Issue 2, 2012, Pages 394-400

  Fysh, Edward T H ^a,b,c   Waterer, Grant W ^c,d   Kendall, Peter A ^c,e   Bremner, Peter R ^e   Dina, Sharifa ^e   Geelhoed, Elizabeth ^b   McCarney, Kate ^a   Morey, Sue ^a   Millward, Michael ^a,c   Musk, A W ^a,b   Lee, Y C Gary ^a,b,c  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d ROYAL PERTH HOSPITAL   (Australia)

^e FREMANTLE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

SERUM ALBUMIN; TALC;

AGED; ALBUMIN BLOOD LEVEL; ARTICLE; AUSTRALIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSPNEA; EMPYEMA; FEMALE; FOLLOW UP; HEMATOTHORAX; HUMAN; INDWELLING CATHETER; INDWELLING PLEURAL CATHETER; INTERMETHOD COMPARISON; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MULTICENTER STUDY; OBSERVATIONAL STUDY; PAIN; PATIENT PREFERENCE; PATIENT SAFETY; PILOT STUDY; PLEURA EFFUSION; PLEURISY; PLEURODESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN DEPLETION; QUALITY OF LIFE; VIDEO ASSISTED THORACOSCOPIC SURGERY;

EID: 84862500621     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-2657     Document Type: Article

References (26)

1. Marel M, Zrustová M, Stasný B, Light RW. The incidence of pleural effusion in a well-defined region. Epidemiologic study in central Bohemia. Chest. 1993;104(5):1486-1489.
2. Efthymiou CA, Masudi T, Thorpe JA, Papagiannopoulos K. Malignant pleural effusion in the presence of trapped lung. Five-year experience of PleurX tunnelled catheters. Interact Cardiovasc Thorac Surg. 2009;9(6):961-964.
3. Khaleeq G, Musani AI. Emerging paradigms in the management of malignant pleural effusions. Respir Med. 2008;102(7):939-948.
4. Heffner JE. Diagnosis and management of malignant pleural effusions. Respirology. 2008;13(1):5-20.
5. Dresler CM, Olak J, Herndon JE 2nd, et al. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest. 2005 ;127(3):909-915.
6. Suzuki K, Servais EL, Rizk NP, et al. Palliation and pleurodesis in malignant pleural effusion: the role for tunneled pleural catheters. J Thorac Oncol. 2011;6(4):762-767.
7. Díez-Porres L, Alonso-Babarro A, Iglesias-Docampo A, Díaz-Agero P. Outpatient management of malignant pleural effusion with chronic pleural catheter. Palliat Med. 2008;22(6):775-776.
8. Tremblay A, Michaud G. Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion. Chest. 2006;129(2):362-368.
9. van den Toorn LM, Schaap E, Surmont VF, Pouw EM, van der Rijt KC, van Klaveren RJ. Management of recurrent malignant pleural effusions with a chronic indwelling pleural catheter. Lung Cancer. 2005;50(1):123-127.
10. Tremblay A, Mason C, Michaud G. Use of tunnelled catheters for malignant pleural effusions in patients fit for pleurodesis. Eur Respir J. 2007;30(4):759-762.
11. Putnam JBJ Jr, Walsh GL, Swisher SG, et al. Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter. Ann Thorac Surg. 2000;69(2):369-375.
12. Putnam JB Jr, Light RW, Rodriguez RM, et al. A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer. 1999;86(10):1992-1999.
13. Lee YCG, Fysh ETH. Indwelling pleural catheter: changing the paradigm of malignant effusion management. J Thorac Oncol. 2011;6(4):655-657.
14. Davies HE, Steer HJ, Fysh ET, Lee YCG. Diagnosis and management of malignant pleural effusion. Minerva Pneumologica. 2010;49(2):237-252.
15. Burrows CM, Mathews WC, Colt HG. Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease. Chest. 2000;117(1):73-78.
16. Yim APC, Chan ATC, Lee TW, Wan IYP, Ho JKS. Thoracoscopic talc insufflation versus talc slurry for symptomatic malignant pleural effusion. Ann Thorac Surg. 1996;62(6):1655-1658.
17. de Boer AGEM, van Lanschot JJB, Stalmeier PFM, et al. Is a single-item visual analogue scale as valid, reliable and responsive as multi-item scales in measuring quality of life? Qual Life Res. 2004;13(2):311-320.
18. Powers J, Bennett SJ. Measurement of dyspnea in patients treated with mechanical ventilation. Am J Crit Care. 1999;8(4):254-261.
19. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003;41(5):582-592.
20. Heffner JE, Nietert PJ, Barbieri C. Pleural fluid pH as a predictor of survival for patients with malignant pleural effusions. Chest. 2000;117(1):79-86.
21. Armstrong BK, Musk AW, Baker JE, et al. Epidemiology of malignant mesothelioma in Western Australia. Med J Aust. 1984;141(2):86-88.
22. Light RW, Lee YCG, eds. Textbook of Pleural Diseases. 2nd ed. London: Hodder Arnold;2008.
23. Olden AM, Holloway R. Treatment of malignant pleural effusion: PleuRx catheter or talc pleurodesis? A cost-effectiveness analysis. J Palliat Med. 2010;13(1):59-65.
24. Goodman A, Davies CW. Efficacy of short-term versus long-term chest tube drainage following talc slurry pleurodesis in patients with malignant pleural effusions: a randomised trial. Lung Cancer. 2006;54(1):51-55.
25. Wrightson JM, Fysh E, Maskell NA, Lee YCG. Risk reduction in pleural procedures: sonography, simulation and supervision. Curr Opin Pulm Med. 2010;16(4):340-350.
26. Van Meter ME, McKee KY, Kohlwes RJ. Efficacy and safety of tunneled pleural catheters in adults with malignant pleural effusions: a systematic review. J Gen Intern Med. 2011;26(1):70-76.